Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2002-07-29
Original market date: See footnote 1
1997-03-24
Product name:
SURFAK 240MG CAPSULES
DIN:
02224666 Electronic product monograph is not available
Company:
AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada
H7V 0A3
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A06AA02 DOCUSATE SODIUM
Active ingredient group (AIG) number:See footnote5
0117478001
Active ingredient(s) | Strength |
---|---|
DOCUSATE CALCIUM | 240 MG / CAP |